We believe in a holistic and comprehensive approach to the treatment of cancer, which includes conventional therapies like chemotherapy, radiation, and immunotherapy. However, those alone are not the best approach for a successful outcome.
This program is adjunctive by design. Patients continue under the care of their oncology team, and nothing here is offered as a replacement for conventional treatment.
What it adds is attention to the terrain: immune function, inflammation, nutritional status, and the microbiome, each of which shapes how a patient tolerates treatment and how well they recover.
Dr. Kellman's role is to support the systems conventional treatment depends on. Immune competence, gut integrity, and nutrient status all influence treatment tolerance and outcomes.
Protocols are individualized and built around what testing shows, using IV therapies, targeted nutrients, and microbiome support coordinated with the timing of oncology treatment.
No. This is an adjunctive program that runs alongside conventional oncology care. Dr. Kellman's position is explicit that conventional therapies are part of a comprehensive approach.
Protocols are designed and timed with that specifically in mind, and are intended to be coordinated with a patient's oncology team.